CGRP receptor antagonists

Details CGRP receptor antagonists CGRP receptor antagonists

2011-08-09

2011-08-09

Desai, Rita (Department: 1625)

Organic compounds -- part of the class 532-570 series

Organic compounds

Heterocyclic carbon compounds containing a hetero ring...

C546S198000, C546S199000, C514S318000

Reexamination Certificate

active

07994325

ABSTRACT:
Compounds of Formula I:(where variables R1, A, B, W, X, Y and Z are as defined herein) useful as antagonists of CGRP receptors and useful in the treatment or prevention of diseases in which the CGRP is involved, such as headache, migraine and cluster headache. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which CGRP is involved.

REFERENCES:
patent: 6953790 (2005-10-01), Burgey et al.
patent: 7452903 (2008-11-01), Burgey et al.
patent: 7491713 (2009-02-01), Burgey et al.
patent: 7534784 (2009-05-01), Burgey et al.
patent: 7772224 (2010-08-01), Paone et al.
patent: WO2004091514 (2004-10-01), None
patent: WO2004092166 (2004-10-01), None
patent: WO2005072308 (2005-08-01), None
Database Caplus on STN: Synthesis and N-substitution of an uncommon heterocyclic system DN 117: 212370. Tetrahedron Letters Issue 32, vol. 33, p. 457104, 1992, Flouzat, et al. English Abstract.
Database CA Online, 1978, Fujita Hiroshi, et al., XP002577480, Accession No. 1978:443299, Compounds with RN 66697-49-2 and 66697-50-5, & 1977, Sankyo Kenkyusko Nenpo, 29, 75-98, CODEN: SKKNAJ: ISSN: 0080-6064.
Nguyen, et al., Bioorganic & Medicinal Chemistry Letters, Pergamon, Elsevier Science, GB LNKD-DOl: 10.1016/J/BMCL.2007.11.042, vol. 18, No. 2, 2007, pp. 755-758, XP022424742, ISSN: 0960-894X.
European Search Report and Search Opinion dated May 7, 2010 for counterpart European Application No. 06748359.4.

Affiliated with

Also associated with

Rating

CGRP receptor antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with CGRP receptor antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and CGRP receptor antagonists will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2732034